Post Marketing Study on Pluvicto in Korea
Recruiting
Observational Study
Metastatic Castration-resistant Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Male
- Study type
- Observational
- Participants needed
- 278 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Post marketing study on Pluvicto in Korea
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
Study participants eligible for inclusion in this study must meet all of the following criteria:
1. Male adult patient age ≥ 18
2. Subject who are being treated with Pluvicto or whose treatment plan is finalized and scheduled to be administered at the time of consent by physicia…
Contacts
Novartis Pharmaceuticals
CONTACT